Frequency and phenotype of EHV-1 specific, IFN-γ synthesising lymphocytes in ponies: The effects of age, pregnancy and infection

Developmental and Comparative Immunology

Volumn 31, Issue 2, 2007, Pages 202-214

  Paillot, Romain ^a   Daly, Janet M ^a   Luce, Richard ^a   Montesso, Fernando ^a   Davis Poynter, Nick ^a   Hannant, Duncan ^a   Kydd, Julia H ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Age; Cd8 T lymphocyte; Equine herpesvirus 1; Equine IFN gamma; Foal; Immunity; Kinetics; Pregnancy

Indexed keywords

CD5 ANTIGEN; CD8ALPHA ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EQUINE ABORTION HERPETOVIRUS; FEMALE; HORSE; IMMUNE DEFICIENCY; INFECTION; LYMPHOCYTE; NONHUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; VIRUS; VIRUS INFECTION;

ANIMALIA; EQUID HERPESVIRUS 1; EQUIDAE;

EID: 33748928959     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2006.05.010     Document Type: Article

References (44)

1. Allen G., Kydd J.H., Slater J., and Smith K.C. Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion. In: U. Wernery J.F.W., Mumford J.A., and Kaaden O.-R. (Eds). Equine infectious diseases VIII: proceedings of the eighth international conference on equine infectious diseases (1999), R&W Publications (Newmarket), Newmarket, UK 129-146
2. Cardwell J., Smith K., Newton R., Blunden T., Bestbier M., and Whitwell K. EHV paralytic disease in the south of England. Vet Rec 152 14 (2003) 441-442
3. Studdert M.J., Hartley C.A., Dynon K., Sandy J.R., Slocombe R.F., Charles J.A., et al. Outbreak of equine herpesvirus type 1 myeloencephalitis: new insights from virus identification by PCR and the application of an EHV-1-specific antibody detection ELISA. Vet Rec 153 14 (2003) 417-423
4. Welch H.M., Bridges C.G., Lyon A.M., Griffiths L., and Edington N. Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J Gen Virol 73 Part 2 (1992) 261-268
5. Slater J.D., Borchers K., Thackray A.M., and Field H.J. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J Gen Virol 75 Part 8 (1994) 2007-2016
6. Gilkerson J.R., Whalley J.M., Drummer H.E., Studdert M.J., and Love D.N. Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet Microbiol 68 1-2 (1999) 15-25
7. Gilkerson J.R., Whalley J.M., Drummer H.E., Studdert M.J., and Love D.N. Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals. Vet Microbiol 68 1-2 (1999) 27-34
8. Kydd J.H., Smith K.C., Hannant D., Livesay G.J., and Mumford J.A. Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet J 26 6 (1994) 470-473
9. Kydd J.H., Smith K.C., Hannant D., Livesay G.J., and Mumford J.A. Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies. Equine Vet J 26 6 (1994) 466-469
10. Crabb B.S., and Studdert M.J. Equine rhinopneumonitis (equine herpesvirus 4) and equine abortion (equine herpesvirus 1). In: Studdert M.J. (Ed). Virus infections of equines (1996), Elsevier, Amsterdam 11-37
11. Wilson W.D., and Rossdale P.D. Effect of age on the serological responses of thoroughbred foals to vaccination with an inactivated EHV-1/EHV-4 vaccine. In: U. Wernery J.F.W., Mumford J.A., and Kaaden O.-R. (Eds). Equine infectious diseases VIII: proceedings of the eighth international conference on equine infectious diseases (1999), R&W Publications (Newmarket), Newmarket, UK 428
12. Foote C.E., Love D.N., Gilkerson J.R., Rota J., Trevor-Jones P., Ruitenberg K.M., et al. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Vet Immunol Immunopathol 105 1-2 (2005) 47-57
13. O'Neill T., Kydd J.H., Allen G.P., Wattrang E., Mumford J.A., and Hannant D. Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. Vet Immunol Immunopathol 70 1-2 (1999) 43-54
14. Kydd J.H., Wattrang E., and Hannant D. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet Immunol Immunopathol 96 3-4 (2003) 207-217
15. Allen G., Yeargan M., Costa L.R., and Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J Virol 69 1 (1995) 606-612
16. Doll E.R., and Bryans J.T. Incubation periods for abortion in equine viral rhinopneumonitis. J Am Vet Med Assoc 141 (1962) 351-354
17. Steinbach F., Mauel S., and Beier I. Recombinant equine interferons: expression cloning and biological activity. Vet Immunol Immunopathol 84 (2002) 83-95
18. Wagner B., Robeson J., McCracken M., Wattrang E., and Antczak D.F. Horse cytokine/IgG fusion proteins-mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines. Vet Immunol Immunopathol 105 1-2 (2005) 1-14
19. Gutmann S., Zawatzky R., and Muller M. Characterisation and quantification of equine interferon gamma. Vet Immunol Immunopathol 104 1-2 (2005) 105-115
20. Hines S.A., Stone D.M., Hines M.T., Alperin D.C., Knowles D.P., Norton L.K., et al. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes. Clin Diagn Lab Immunol 10 2 (2003) 208-215
21. Fraser D.G., Oaks J.L., Brown W.C., and McGuire T.C. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus. Immunology 105 3 (2002) 295-305
22. Soboll G., Horohov D.W., Aldridge B.M., Olsen C.W., McGregor M.W., Drape R.J., et al. Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet Immunol Immunopathol 94 1-2 (2003) 47-62
23. Breathnach C.C., Rudersdorf R., and Lunn D.P. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination. Vet Immunol Immunopathol 98 3-4 (2004) 127-136
24. Paillot R., Daly J., Juillard V., Minke J.M., Hannant D., and Kydd J.H. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine 23 36 (2005) 4541-4551
25. Paillot R., Ellis S.A., Daly J.M., Audonnet J.C., Minke J.M., Davis-Poynter N., et al. Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24 10 (2006) 1490-1500
26. Breathnach C.C., Soboll G., Suresh M., and Lunn D.P. Equine herpesvirus-1 infection induces IFN-γ production by equine T lymphocyte subsets. Vet Immunol Immunopathol 103 3-4 (2005) 207-215
27. Mumford J.A., Hannant D., Jessett D.M., O'Neill T., Smith K.C., and Ostlund E.N. Abortigenic and neurological disease caused by experimental infection with Equid herpesvirus-1. In: Nakajima H., and Plowright W. (Eds). Equine infectious diseases VII: proceedings of seventh international conference on equine infectious diseases (1994), R & W Publications Ltd., Newmarket, UK 261-275
28. Telford E.A., Watson M.S., McBride K., and Davison A.J. The DNA sequence of equine herpesvirus-1. Virology 189 1 (1992) 304-316
29. Paillot R, Kydd J, Sindle TDH, Edlund Toulemonde C, Audonnet JC, et al. Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet Immunol Immunopathol 2006;in press.
30. Ouyang Q., Wagner W.M., Zheng W., Wikby A., Remarque E.J., and Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 39 4 (2004) 607-613
31. Khan N., Hislop A., Gudgeon N., Cobbold M., Khanna R., Nayak L., et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 173 12 (2004) 7481-7489
32. Patel J.R., and Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)-epidemiology, disease and immunoprophylaxis: a brief review. Vet J 170 1 (2005) 14-23
33. Horohov D.W., Kydd J.H., and Hannant D. The effect of aging on T cell responses in the horse. Dev Comp Immunol 26 1 (2002) 121-128
34. Boren E., and Gershwin M.E. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev 3 5 (2004) 401-406
35. Zanni F., Vescovini R., Biasini C., Fagnoni F., Zanlari L., Telera A., et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 38 9 (2003) 981-987
36. Alberti S., Cevenini E., Ostan R., Capri M., Salvioli S., Bucci L., et al. Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4(+) T cells in humans. Mech Ageing Dev (2006)
37. Crough T., Burrows J.M., Fazou C., Walker S., Davenport M.P., and Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol 35 1 (2005) 139-149
38. O'Neill T. T lymphocyte responses to Equid Herpesvirus 1 and 4 in horses. Ph.D. thesis, Open University, 1995. p. 300.
39. Meeusen E.N., Bischof R.J., and Lee C.S. Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol 46 2 (2001) 169-179
40. Roth T.L., White K.L., Thompson Jr. D.L., Rahmanian S., and Horohov D.W. Involvement of interleukin 2 receptors in conceptus-derived suppression of T and B cell proliferation in horses. J Reprod Fertil 96 1 (1992) 309-322
41. Lunn D.P., Schram B.R., Vagnoni K.E., Schobert C.S., Horohov D.W., and Ginther O.J. Positive selection of EqCD8+ precursors increases equine lymphokine-activated killing. Vet Immunol Immunopathol 53 1-2 (1996) 1-13
42. Viveiros M.M., and Antczak D.F. Characterization of equine natural killer and IL-2 stimulated lymphokine activated killer cell populations. Dev Comp Immunol 23 6 (1999) 521-532
43. Asanuma H., Sharp M., Maecker H.T., Maino V.C., and Arvin A.M. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 181 3 (2000) 859-866
44. Waldrop S.L., Pitcher C.J., Peterson D.M., Maino V.C., and Picker L.J. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 99 7 (1997) 1739-1750